Fermer le menu


Member of Lyonbiopole


We leverage our disruptive, Artificial Intelligence (AI) based, proprietary discovery process to discover and patent active ingredients and products based on patentable mixes of plant extracts with a history of safe human consumption to bring new human and animal therapeutic solutions, with a superior efficacy and reduced risks of side effects relative to traditional mono-compound approaches. We concentrate our discovery efforts on the selective elimination of deleterious cells and micro-organisms, including their biofilms, with an initial focus on genuine alternatives to antibiotics and anti-cancer products.


Strategic application domain: Human Medicine

Application market: Infectious Diseases, Oncology

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Others

Created on oct. 29th, 2014 - 5 employees



20-22 rue Henri et Gilberte Goudier 63200 Riom



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.